Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vasily Gelfanov

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Organic Letters|November 5, 2016
Synthetic Route to Human Relaxin-2 via Iodine-Free Sequential Disulfide Bond FormationXu Yang, Vasily Gelfanov, Fa Liu, et al.
Accounts of Chemical Research|August 4, 2017
Synthetic Advances in Insulin-like Peptides Enable Novel BioactivityFa Liu, Pengyun Li, Vasily Gelfanov, et al.
Protein and Peptide Letters|November 2, 2018
Structurally Constrained Insulin Analogs by Directed Stepwise CrosslinkingFa Zhang, John P Mayer, Vasily Gelfanov, et al.
Molecular Metabolism|August 17, 2021
A viral insulin-like peptide is a natural competitive antagonist of the human IGF-1 receptorFa Zhang, Emrah Altindis, C Ronald Kahn, et al.
Organic Letters|January 27, 2017
Biomimetic Synthesis of Insulin Enabled by Oxime Ligation and Traceless "C-Peptide" Chemical ExcisionKishore Thalluri, Binbin Kou, Vasily Gelfanov, et al.
Molecular Metabolism|April 22, 2014
A glucagon analog chemically stabilized for immediate treatment of life-threatening hypoglycemiaJoseph Chabenne, Maria Dimarchi Chabenne, Yan Zhao, et al.
Journal of Medicinal Chemistry|August 11, 2016
Pyridyl-alanine as a Hydrophilic, Aromatic Element in Peptide Structural OptimizationPiotr A Mroz, Diego Perez-Tilve, Fa Liu, et al.
Bioorganic & Medicinal Chemistry|November 21, 2017
Optimization of peptide-based polyagonists for treatment of diabetes and obesityPatrick J Knerr, Brian Finan, Vasily Gelfanov, et al.
Molecular Metabolism|December 23, 2018
Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonismPiotr A Mroz, Brian Finan, Vasily Gelfanov, et al.
Cell Metabolism|July 14, 2016
Unimolecular Polypharmacy for Treatment of Diabetes and ObesityMatthias H Tschöp, Brian Finan, Christoffer Clemmensen, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Organic Letters|November 5, 2016
Synthetic Route to Human Relaxin-2 via Iodine-Free Sequential Disulfide Bond FormationXu Yang, Vasily Gelfanov, Fa Liu, et al.
Accounts of Chemical Research|August 4, 2017
Synthetic Advances in Insulin-like Peptides Enable Novel BioactivityFa Liu, Pengyun Li, Vasily Gelfanov, et al.
Protein and Peptide Letters|November 2, 2018
Structurally Constrained Insulin Analogs by Directed Stepwise CrosslinkingFa Zhang, John P Mayer, Vasily Gelfanov, et al.
Molecular Metabolism|August 17, 2021
A viral insulin-like peptide is a natural competitive antagonist of the human IGF-1 receptorFa Zhang, Emrah Altindis, C Ronald Kahn, et al.
Organic Letters|January 27, 2017
Biomimetic Synthesis of Insulin Enabled by Oxime Ligation and Traceless "C-Peptide" Chemical ExcisionKishore Thalluri, Binbin Kou, Vasily Gelfanov, et al.
Molecular Metabolism|April 22, 2014
A glucagon analog chemically stabilized for immediate treatment of life-threatening hypoglycemiaJoseph Chabenne, Maria Dimarchi Chabenne, Yan Zhao, et al.
Journal of Medicinal Chemistry|August 11, 2016
Pyridyl-alanine as a Hydrophilic, Aromatic Element in Peptide Structural OptimizationPiotr A Mroz, Diego Perez-Tilve, Fa Liu, et al.
Bioorganic & Medicinal Chemistry|November 21, 2017
Optimization of peptide-based polyagonists for treatment of diabetes and obesityPatrick J Knerr, Brian Finan, Vasily Gelfanov, et al.
Molecular Metabolism|December 23, 2018
Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonismPiotr A Mroz, Brian Finan, Vasily Gelfanov, et al.
Cell Metabolism|July 14, 2016
Unimolecular Polypharmacy for Treatment of Diabetes and ObesityMatthias H Tschöp, Brian Finan, Christoffer Clemmensen, et al.
Pageof 3